| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |